Aurobindo Pharma said the US FDA completed inspection of Apitoria Pharma Unit-V in Telangana, and issued Form 483 with three procedural observations, with no impact on operations. Shares of the company ended close to 2% in the green on Friday, December 12. The stock has fallen over 11% in the year so far.
